Table 1.

Clinical characteristics of the study population

	Summary statistics
Age, years	13±2
Gender, male %	75%
Tanner stage	Tanner stage 1, 19.6%; Tanner stages 2–4, 65.2%; Tanner stage 5, 15.2%
BMI	34±8
Steatosis	G0: 1.8%; G1: 37.5%; G2: 21.4%; G3: 39.3%
Lobular inflammation	G0: 3.6%; G1: 87.5%; G2: 8.9%; G3: 0%
Hepatocyte ballooning	G0: 76.8%; G1:17.9%; G2: 5.3%
Portal inflammation	G0: 30.9%; G1:45.5%; G2: 23.6
Diagnostic category	Steatosis: 35.7%; Suspicious SH:46.5%; SH adult pattern:14.3%; SH pediatric pattern: 2:3.6%
Fibrosis	S0: 30.2%; S1: 24.5%; S2: 7.5%; S3: 34.0%; S4: 3.8%
NAS score	3[2, 4]

G: histologic grade; SH: steatohepatitis; S: stage